Identification of fibroblast heterogeneity in the tumor microenvironment

Tumors are unorganized organs that contain many different cell types. In the recent years, many studies have reported that primary tumors contain fibroblasts/myofibroblasts (carcinoma-associated fibroblasts), mesenchymal cells such as pericytes/mural cells and other vascular smooth muscle cells. Several different markers are used routinely to identify carcinoma-associated fibroblasts (CAFs) such as alpha-smooth muscle actin (α-SMA), vimentin, S100A4 protein/fibroblast specific protein-1 (FSP1) and type I collagen. Likewise markers such as platelet derived growth factor receptor-beta (PDGFRβ) and NG2 chondroitin sulfate proteoglycan (NG2) are used to identify mesenchymal cells such as pericytes and other vasculature associated smooth muscle cells. It is still unknown whether these markers overlap with each other or identify a unique population of cells within the tumor microenvironment. Therefore in the present study we utilized two different mouse models of cancer, the Rip1Tag2 mice that develop progressive pancreatic cancer and an orthotopic 4T1 breast cancer model, to study the overlap between six different mesenchymal markers commonly used in mouse cancer research. Our study demonstrates that among all the markers, S100A4/FSP1 identifies a unique population of fibroblasts with minimal overlap with markers for αSMA, PDGFRβ and NG2. Vimentin and type I collagen are not specific markers for fibroblasts in these tumors. αSMA, PDGFRβ and NG2 significantly overlap with each other in identifying a mixed population of fibroblasts (activated or resting), myofibroblasts, pericytes and vascular smooth muscle cells. Collectively, this study demonstrates that tumor microenvironment associated fibroblasts are a heterogeneous population and thus, the use of αSMA or vimentin as the only markers will not identify all the CAFs.

[1]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[2]  W. Stallcup,et al.  Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[4]  E. Baetge,et al.  Antisera specific for cell lines with mixed neuronal and glial properties. , 1981, Developmental biology.

[5]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[6]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[7]  H. Makino,et al.  Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy , 1998, Diabetologia.

[8]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[9]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[10]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[11]  D. Hanahan,et al.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.

[12]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[13]  G. Gabbiani,et al.  Myofibroblasts in human granulation tissue. , 1974, Human pathology.

[14]  O. Petersen,et al.  Regulation of vimentin expression in cultured human mammary epithelial cells. , 1990, Differentiation; research in biological diversity.

[15]  R. Weichselbaum,et al.  Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.

[16]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[17]  R. Kalluri,et al.  Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[19]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[20]  C. Grund,et al.  Intermediate-sized filaments present in Sertoli cells are of the vimentin type. , 1979, European journal of cell biology.

[21]  W. Kriz,et al.  Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells. , 1999, Journal of the American Society of Nephrology : JASN.

[22]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[23]  W. Stallcup,et al.  High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.

[24]  K Weber,et al.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Gabbiani,et al.  Myofibroblasts in an avascular fibrous tissue. , 1973, Laboratory investigation; a journal of technical methods and pathology.